Table 2 List of the included gray literatures
From: Causes and consequences of quack medicine in health care: a scoping review of global experience
First Author | Date | Title | Publisher |
|---|---|---|---|
Bagozzi | 2003 | World Health Organization steps up action against substandard and counterfeit medicines | World Health Organization |
Lindmeier | 2017 | Seventieth World Health Assembly update, 29 May 2017 | WHO |
Dovlo | 2016 | Dr Moeti proposes actions to address fake medical products | WHO |
Kasilo | 2014 | We must prevent the production, marketing and use of unsafe medical products, says Dr Sambo, WHO Regional Director for Africa | WHO |
Trapsida | 2010 | Interventions for prevention and control of substandard/spurious/falsely labelled/falsified and/or counterfeit medical products in the WHO African Region | WHO |
- | 2013 | Know the Risks | U.S. Food and Drug Administration |
- | 2020 | About Be Safe Rx | U.S. Food and Drug Administration |